Nextgen Biomed Ltd

Nextgen Biomed Ltdverified

NXGN.TA

Price:

$48.7

Market Cap:

$5.68M

Nextgen Biomed Ltd develops topical treatment for psoriasis. The company was formerly known as Sela Group.Com Ltd. and changed its name to Nextgen Biomed Ltd in February 2010. Nextgen Biomed Ltd was incorporated in 1990 and is based in Tel Aviv, Israel.

Industry

Medical - Instruments & Supplies

IPO Date

2002-08-12

Stock Exchange

TLV

Ticker

NXGN.TA

The ROE as of December 2025 (TTM) for Nextgen Biomed Ltd (NXGN.TA) is 182.79%

According to Nextgen Biomed Ltd’s latest financial reports and current stock price. The company's current ROE is 182.79%. This represents a change of 226.42% compared to the average of 56.00% of the last 4 quarters.

Nextgen Biomed Ltd (NXGN.TA) Historical ROE (quarterly & annually)

How has NXGN.TA ROE performed in the past?

The mean historical ROE of Nextgen Biomed Ltd over the last ten years is 129.91%. The current 182.79% ROE has changed 40.71% with respect to the historical average. Over the past ten years (40 quarters), NXGN.TA's ROE was at its highest in in the September 2023 quarter at 703.55%. The ROE was at its lowest in in the June 2020 quarter at -137.57%.

Quarterly (TTM)
Annual

Average

129.91%

Median

-37.31%

Minimum

-238.95%

Maximum

1.65%

Nextgen Biomed Ltd (NXGN.TA) ROE by Quarter and Year

Discovering the peaks and valleys of Nextgen Biomed Ltd ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 465.90%

Maximum Annual ROE = 1.65%

Minimum Annual Increase = -2479.67%

Minimum Annual ROE = -238.95%

Quarterly (TTM)
Annual
YearROEChange
2024208.97%-87.34%
20231.65%-2479.67%
2022-69.35%465.90%
2021-12.25%-34.10%
2020-18.60%-80.53%
2019-95.52%87.78%
2018-50.87%27.21%
2017-39.98%15.44%
2016-34.64%-85.50%
2015-238.95%-140.42%

Nextgen Biomed Ltd (NXGN.TA) Average ROE

How has NXGN.TA ROE performed in the past?

The current ROE of Nextgen Biomed Ltd (NXGN.TA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

596.62%

5-year avg

351.80%

10-year avg

129.91%

Nextgen Biomed Ltd (NXGN.TA) ROE vs. Peers

How is NXGN.TA’s ROE compared to its peers?

Nextgen Biomed Ltd’s ROE is

CompanyROEMarket cap

Build a custom stock screener for Nextgen Biomed Ltd (NXGN.TA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nextgen Biomed Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nextgen Biomed Ltd (NXGN.TA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nextgen Biomed Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Nextgen Biomed Ltd's ROE?

How is the ROE calculated for Nextgen Biomed Ltd (NXGN.TA)?

What is the highest ROE for Nextgen Biomed Ltd (NXGN.TA)?

What is the 3-year average ROE for Nextgen Biomed Ltd (NXGN.TA)?

What is the 5-year average ROE for Nextgen Biomed Ltd (NXGN.TA)?

How does the current ROE for Nextgen Biomed Ltd (NXGN.TA) compare to its historical average?